Elevated levels of IL-1 family cytokines, particularly IL-1β and IL-36, have been observed in both lesional and non-lesional HS skin, suggesting that persistent inflammasome activation underlies systemic immune dysregulation in HS. The gene discussed is IL1B; the disease is histiocytic sarcoma.